Anti-Urolithiatic Potential of Catharanthus Roseus Aqueous and Ethanolic Leaf Extractions: An Invitro Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Urolithiasis is the formation of calcium oxalate crystals within the urinary tract and kidney. The use of plant-based (natural) therapies for the treatment of kidney stones that exhibit few or less severe side effects than standard therapies. Background: The aim of this study was to evaluate the anti-urolithiasis potential of the aqueous and ethanolic extract of Catharanthus roseus leaves compared to the standard drug, using an in-vitro calcium oxalate crystallisation method. Methods: Leaves of the Catharanthus roseus plant were shade dried, powdered, and then extracted using aqueous and ethanolic solvents according to standard extraction techniques documented in the published literature. Preliminary phytochemical screening of the extracts was conducted to determine the major bioactive components of the extracts. The ability of each extract to prevent the formation of calcium oxalate crystals was determined using the egg membrane pouch method, and then determined using a modified KMnO4 titration method. Results: The aqueous extract of Catharanthus roseus inhibited the formation of calcium oxalate crystals by 64.5% while the ethanolic extract produced 61% inhibition, and the standard drug Neeri produced 70% inhibition of calcium oxalate crystal formation. These findings suggest that both aqueous and ethanolic extracts of Catharanthus roseus leaves exhibit significant anti-urolithiasis activity. Conclusions: The results of this study show that Catharanthus roseus leaf extract shows an effective anti-urolithiatic agent by reducing the formation of calcium oxalate crystals. There is a need for additional in-vivo and clinical research in order to determine its specific effectiveness in humans.
Fields of Study & Subjects
Kidney Stones and Urolithiasis Treatments
Medicinal Plant Research
Gout
Hyperuricemia
Uric Acid
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 25 March 2026
- Language
- EN